PharmaNet expects the news of a second office in the region to be well received by its clients and the company looks forward to increasing the number of clinical trials currently taking place in Brazil.
The new office will enable the company to meet the current and future needs of its clients, expedite the execution of clinical studies and continue the growth of strategic relationships with investigators and sites in Brazil.
Fernanda Duran, executive director of Latin American operations at PharmaNet, said: “The number of clinical trials in Latin America has experienced significant growth over the past 10 years. Our clients are more actively requesting Latin American sites in order to meet aggressive timelines for patient recruitment, thus bringing their new drugs to market sooner. I am thrilled about opening this office in Brazil which will enhance our infrastructure in the region.”